Soleno Therapeutics adds 500,000 shares to inducement equity plan for new hires

SOLENO THERAPEUTICS INC

Board amended 2020 Inducement Plan to increase share reserve by 500,000 shares.
Amendment adopted without stockholder approval under Nasdaq Rule 5635(c)(4).
Plan used for equity awards as material inducement for new employees not previously employed.
Total shares authorized under plan now 2,000,000 (original 1,500,000 + 500,000).
Awards may include options, RSUs, restricted stock, SARs, performance shares/units.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.